{
  "id": 17819811,
  "title": "Karyopharm plans to merge with Ayrmid, the company that tried buying bluebird",
  "url": "https://urgent.news/2026/11/02/karyopharm-plans-to-merge-with-ayrmid-the-company-that-tried-buying",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-02T15:28:10.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/karyopharm-plans-to-merge-with-ayrmid-the-company-that-tried-buying-bluebird/"
  },
  "original_language": "en",
  "account": null,
  "summary": "With few options remaining, a commercial-stage blood cancer biotech will go through a bankruptcy process and plans to merge with another drugmaker in the blood disorder field. Karyopharm Therapeutics, maker of the multiple myeloma drug ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}